Wednesday, December 03, 2025 | 03:45 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

SC rejects CCI order against GSK, Sanofi

A lawyer for CCI argued it had evidence that companies engaged in tender rigging

Supreme Court of India
premium

Supreme Court

Veena Mani New Delhi
The Supreme Court on Thursday upheld the Competition Appellate Tribunal's (Compat's) order quashing a penalty of Rs 64 crore imposed by the Competition Commission of India (CCI) on multinational drug makers GlaxoSmithKline and Sanofi Pasteur for alleged bid rigging to supply vaccines for Haj pilgrims.

The two companies were accused of colluding in bids for the Quadrivalent Meningococcal Meningitis Vaccine in tenders floated by the Union Health Ministry. GSK and Sanofi Pasteur had first appealed to Compat.

A lawyer on the case told Business Standard that the apex court cited that the facts and figures did not make for a